[Objectives and methods in therapy of essential arterial hypertension].
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002752:Chlorthalidone / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use*; D004976:Ethacrynic Acid / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D008750:Methyldopa / Q000627:therapeutic use; D011188:Potassium / Q000627:therapeutic use*; D012110:Reserpine / Q000627:therapeutic use; D014223:Triamterene / Q000627:therapeutic use
D000959:Antihypertensive Agents; D004232:Diuretics; D006852:Hydrochlorothiazide; D006830:Hydralazine; D008750:Methyldopa; D012110:Reserpine; D004976:Ethacrynic Acid; D002752:Chlorthalidone; D011188:Potassium; D014223:Triamterene; D006145:Guanethidine
Obiettivi e mezzi nella terapia dell'ipertensione arteriosa essenziale.